A Smart Drug Delivery Platform
Peptinovo’s patented technology offers a targeted smart drug delivery platform designed to improve the efficacy of a variety of proven, approved chemotherapies on a broad range of solid tumors while greatly reducing the serious side effects that limit chemotherapy success.
Our Promising Pipeline is Set to Change Cancer Treatment
We are currently preparing to begin clinical trials on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.
A Team of Proven Industry Veterans
Peptinovo’s seasoned team has launched three drugs from idea to market, started seven individual pharma companies with 3 exits and 4 ongoing compaines, and led all aspects needed to develop, test, and launch pharmacology products.
